Cargando…
PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington’s disease
Huntington’s disease (HD) is caused by an expanded CAG repeat in huntingtin (HTT). Since HD is dominant and loss of HTT leads to neurological abnormalities, safe therapeutic strategies require selective inactivation of mutant HTT. Previously, we proposed a concept of CRISPR-Cas9 using mutant-specifi...
Autores principales: | Shin, Jun Wan, Hong, Eun Pyo, Park, Seri S., Choi, Doo Eun, Zeng, Sophia, Chen, Richard Z., Lee, Jong-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450073/ https://www.ncbi.nlm.nih.gov/pubmed/36092363 http://dx.doi.org/10.1016/j.omtm.2022.08.005 |
Ejemplares similares
-
Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9
por: Shin, Jun Wan, et al.
Publicado: (2022) -
CrisPam: SNP-Derived PAM Analysis Tool for Allele-Specific Targeting of Genetic Variants Using CRISPR-Cas Systems
por: Rabinowitz, Roy, et al.
Publicado: (2020) -
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
por: Kleinstiver, Benjamin P., et al.
Publicado: (2015) -
Programming PAM antennae for efficient CRISPR-Cas9 DNA editing
por: Wang, Fei, et al.
Publicado: (2020) -
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes
por: Vicencio, Jeremy, et al.
Publicado: (2022)